Injexate

Methotrexate, the active ingredient in Injexate, is an antimetabolite (folate antagonist) presented as an injectable solution for intramuscular, intravenous, or subcutaneous use. It is employed to treat autoimmune disorders and certain cancers in adult patients.

GNH USA supplies Injexate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution. Customers benefit from reliable logistics, temperature‑controlled shipping where required, and responsive technical support throughout the procurement process.

Methotrexate is used across several disease families, primarily targeting immune‑mediated conditions and hematologic malignancies.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin lesion severity and plaque formation. - Acute lymphoblastic leukemia: impedes malignant cell proliferation in the bone marrow. - Non‑Hodgkin lymphoma: contributes to tumor regression as part of combination chemotherapy.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Fatigue: persistent tiredness. - Oral ulcers: painful sores in the mouth. - Elevated liver enzymes: mild hepatic irritation.

Serious or Rare Side Effects: - Severe liver toxicity: risk of hepatitis or fibrosis. - Pulmonary fibrosis: progressive lung scarring. - Bone marrow suppression: profound pancytopenia. - Severe infection: opportunistic infections due to immunosuppression.

When using methotrexate, careful monitoring and specific precautions are essential to minimize risks. - Pregnancy contraindication: avoid use in pregnancy due to teratogenicity. - Liver monitoring: perform regular liver function tests. - Blood count monitoring: check complete blood count before and during therapy. - Renal function: adjust dose in patients with impaired kidney function. - Drug interactions: avoid concomitant use with NSAIDs and aminoglycosides without supervision. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methotrexate interacts with several medicines; recognizing the level of interaction guides clinical management.

Major Interactions (Avoid): - NSAIDs: increase methotrexate toxicity by reducing renal clearance. - Aminoglycoside antibiotics: heighten risk of nephrotoxicity. - Live vaccines: may cause severe infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may alter absorption and increase serum levels. - Sulfonamide antibiotics: can enhance hematologic toxicity. - Oral contraceptives: may reduce efficacy of hormonal contraception.